Evidence map›Paper›PMID 39202615›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.

Yuka Hayashi, Kazuto Tajiri, Tatsuhiko Ozawa, Kiyohiko Angata, Takashi Sato, Akira Togayachi, Izuru Nagashima, Hiroki Shimizu, Aiko Murayama, Nozomu Muraishi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuka HayashiThird Department of Internal Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Kazuto TajiriThird Department of Internal Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.ORCID 0000-0002-2373-8601
Tatsuhiko OzawaDepartment of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Kiyohiko AngataCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8560, Japan.
Takashi SatoCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8560, Japan.ORCID 0000-0002-9973-8923
Akira TogayachiCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8560, Japan.
Izuru NagashimaCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8560, Japan.
Hiroki ShimizuCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8560, Japan.ORCID 0000-0002-6599-5358
Aiko MurayamaThird Department of Internal Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Nozomu MuraishiThird Department of Internal Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Hisashi NarimatsuCellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8560, Japan.
Ichiro YasudaThird Department of Internal Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.ORCID 0000-0002-6888-0310

Funding

Japan Agency for Medical Research and Development JP22am0101077Japan Society for the Promotion of Science JP17K09410, JP23K07373
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicHepatitis B Surface AntigensAdultAntibodies, MonoclonalEpitopesFemaleGenotypeHepatitis B virusHumansMaleMiddle AgedProtein PrecursorsAntibodies, MonoclonalEpitopesHepatitis B Surface Antigenspresurface protein 1, hepatitis B surface antigenProtein PrecursorsHBsAgHB surface proteinHBV entrymonoclonal antibodypreS1

Identifiers

PMID39202615
PMCPMC11356368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.